MENU
+Compare
QNRX
Stock ticker: NASDAQ
AS OF
Dec 26 closing price
Price
$13.99
Change
+$0.09 (+0.65%)
Capitalization
11.74M

QNRX Quoin Pharmaceuticals Ltd Forecast, Technical & Fundamental Analysis

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases... Show more

Industry: #Biotechnology
QNRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for QNRX with price predictions
Dec 26, 2025

QNRX in upward trend: price may jump up because it broke its lower Bollinger Band on December 05, 2025

QNRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where QNRX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 23, 2025. You may want to consider a long position or call options on QNRX as a result. In of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where QNRX advanced for three days, in of 217 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for QNRX moved out of overbought territory on December 01, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for QNRX turned negative on December 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .

QNRX moved below its 50-day moving average on December 18, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for QNRX crossed bearishly below the 50-day moving average on December 15, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QNRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for QNRX entered a downward trend on December 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.925) is normal, around the industry mean (26.614). P/E Ratio (0.012) is within average values for comparable stocks, (51.532). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (310.546).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. QNRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QNRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
QNRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of biological products for cellular therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
42127 Pleasant Forest Court
Phone
+1 703 980-4182
Employees
4
Web
https://www.quoinpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TK9.180.07
+0.77%
Teekay Corporation Ltd
ALTG4.720.02
+0.43%
Alta Equipment Group
BANF109.730.14
+0.13%
BancFirst Corp
WDS15.36-0.06
-0.39%
Woodside Energy Group Limited
CMMB1.80-0.08
-4.26%
Chemomab Therapeutics Ltd

QNRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, QNRX has been loosely correlated with NEVPF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if QNRX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNRX
1D Price
Change %
QNRX100%
+0.65%
NEVPF - QNRX
38%
Loosely correlated
N/A
ATNM - QNRX
35%
Loosely correlated
-4.40%
PRQR - QNRX
32%
Poorly correlated
N/A
WVE - QNRX
32%
Poorly correlated
-2.63%
PTGX - QNRX
29%
Poorly correlated
-0.07%
More